Zirwas, M.; Draelos, Z.; Dubois, J.; Kircik, L. .; Moore, A.; Stein Gold, L.; Alonso-Llamazares, J. .; Bukhalo, M.; Bruce, S.; Eads, K.; Green, L.; Guenthner, S.; Ferris, L.; Forman, S.; Kempers, S.; Lain, E. .; Lynde, C.; Pariser, D.; Pariser, D.; Toth, D.; Yamauchi, paul; Burnett, P.; Berk, D. A Randomized, Double-Blind, Vehicle-Controlled Phase 2a Study Evaluating Once Daily Roflumilast Foam 0.3% in Patients With Moderate to Severe Seborrheic Dermatitis. J of Skin 2021, 5, s94.